Our results suggested ATO induced cyclin D1 degradation has a similar effect to CDK4/6 inhibitors, caused inhibition of CDK4/6 signaling, induced cancer cell senescence, and inhibited SCC outgrowth in 4NQO induced OSCC and ESCC mouse models in vivo. This evidence concerns the gene CCND1 and cancer.